HLA-A 抗体 (PE-Cy7)
Quick Overview for HLA-A 抗体 (PE-Cy7) (ABIN2659358)
抗原
See all HLA-A 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    
- 
                                            
交叉反应
 - Chimpanzee, Baboon, Cynomolgus, 猕猴, 牛, 猫
 - 
                                            
纯化方法
 - The antibody was purified by affinity chromatography and conjugated with PE/Cy7 under optimal conditions. The solution is free of unconjugated PE/Cy7 and unconjugated antibody.
 - 
                                            
亚型
 - IgG2a kappa
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
应用备注
 - Optimal working dilution should be determined by the investigator.
 - 
                                            
限制
 - 仅限研究用
 
 - 
                                            
 - 
    
- 
                                            
缓冲液
 - Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .
 - 
                                            
储存液
 - Sodium azide
 - 
                                            
注意事项
 - This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
注意事项
 - Protect from prolonged exposure to light. Do not freeze.
 - 
                                            
储存条件
 - 4 °C
 - 
                                            
储存方法
 - The antibody solution should be stored undiluted between 2°C and 8°C.
 
 - 
                                            
 - 
    
- HLA-A (Major Histocompatibility Complex, Class I, A (HLA-A))
 - 
                                            
别名
 - HLA-A
 - 
                                            
背景
 - MHC class I antigens associated with β2-microglobulin are expressed by all human nucleated cells. MHC class I molecules are involved in presentation of antigens to CD8+ T cells. They play an important role in cell-mediated immune responses and tumor surveillance.
 - 
                                            
途径
 - TCR Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
 
抗原
 -